decreased survivor rate_Tg(CMV-cre)1Cgn/0,Tg(Kit*D814V)3Roer/0

http://metadb.riken.jp/0008770IBALBcJC57BL6TgCMVcre1Cgn0TgKitD814V3Roer0TgCMVcre1CgnTgKitD814V3Roer

decreased survivor rate_Tg(CMV-cre)1Cgn/0,Tg(Kit*D814V)3Roer/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 1, University of Cologne
  http://metadb.riken.jp/db/mgi_rdf/MGI:2176179
• transgene insertion 3, Axel Roers
  http://metadb.riken.jp/db/mgi_rdf/MGI:4942356

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(CMV-cre)1Cgn/0,Tg(Kit*D814V)3Roer/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(CMV-cre)1Cgn|Tg(Kit*D814V)3Roer

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: BALB/cJ * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased survivor rate
  http://purl.obolibrary.org/obo/MP_0008770

文献

http://purl.org/net/cito/citesAsAuthority

• Alexander. Gerbaulet, et.al., Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit., Blood, 2011, 117
  http://rdf.ncbi.nlm.nih.gov/pubmed/21148330